Business News

The FDA approves the emergency for the primary residence Covid-19 check package

Covid-19 nasal swab test on patient.

Lisa Maree Williams | Getty Images News | Getty Images

The U.S. Food and Drug Administration (FDA) has approved emergency use for the first Covid-19 test that can be done entirely at home.

The agency has approved the single-use test, which provides results within 30 minutes, to anyone aged 14 and over if their healthcare provider suspects Covid-19.

The kit was made by Lucira Health, a privately held California biotech company, and can also be used in hospitals. However, patients under the age of 14 must have their sample drawn by a healthcare provider.

The FDA has not disclosed the price of the test. The company's website says the test will "cost less than $ 50".

"While Covid-19 diagnostic tests have been approved for collection at home, this is the first that is fully self-administered and provides results at home," said FDA Commissioner Stephen Hahn in a press release.

"This new testing option is an important diagnostic advance to tackle the pandemic and reduce the public burden of disease transmission," he added.

In the nasal swab test, a patient's self-collected sample swab is swirled in a vial which is then placed in a test unit. The results are then made visible on the test's luminous display within 30 minutes.

The FDA noted that people who tested positive should self-isolate and get additional care from their health care provider. Those who do negative tests and have Covid-like symptoms should also see their doctor, he added.

Related Articles